Short answer
Revvity (RVTY) filed its Q1 2025 10-Q quarterly report on May 6, 2025 for the quarter ended Mar 30, 2025. Quarterly revenue was $665M (up 2.3% year over year) with net income of $42M.
Q1 2025 key financials · XBRL
- Revenue
- $665M
- +2.3% YoY
- Net income
- $42M
- +62.4% YoY
- Operating margin
- 10.9%
- EPS (diluted)
- $0.35
- +66.7% YoY
Source: XBRL data from the Revvity (RVTY) Q1 2025 10-Q on SEC EDGAR. USD.
Revvity Q1 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $664.8M, up 2% YoY from $649.9M; Life Sciences $340.4M (+1%), Diagnostics $324.4M (+3%)
- Gross margin 56.5% vs 54.6% YoY; SG&A margin 37.6% vs 40.1% YoY; R&D margin 8.1% vs 7.7% YoY
- Best segment: Life Sciences operating income $105.7M (+5%), margin +106bps; Worst: Diagnostics operating income $74.0M (-3%), margin down 150bps
- Cash and equivalents $1.14B; Operating cash flow $134.1M vs $150.1M YoY; $153.6M stock repurchases vs $10.8M
- Management expects 20% effective tax rate for FY25; tariff impact on operating income approx. $20M; share repurchase program $707.2M remaining
Risk Factors
- New risk: Cautious customer spending due to recent and proposed U.S. funding and regulatory uncertainties impacting government and industrial funding approvals
- Most materially updated risk: Increased supply chain risks from global conflicts and tariffs, including Ukraine war and retaliatory trade measures affecting costs and delivery
- Regulatory risk: Heightened data privacy and information security laws, with potential significant fines and operational impacts for noncompliance in U.S., EU, and UK markets
- Near-term operational risk: Significant disruption risk in third-party shipping providers like UPS and DHL, potentially increasing costs and delaying deliveries, affecting profitability
- Financial risk: Substantial debt with multi-year notes due 2026 to 2051, variable rate exposure, foreign currency risk, and restrictive covenants limiting financial and operational flexibility
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Revvity quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.